» Authors » Ranjana Nawgiri

Ranjana Nawgiri

Explore the profile of Ranjana Nawgiri including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 47
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hussain M, Ghani H, Ali Y, Clement C, Nawgiri R
Diagn Cytopathol . 2024 May; 52(7):387-392. PMID: 38712593
Introduction: F-fluorodeoxyglucose (FDG) uptake on positron emission tomography/computed tomography (PET/CT) has become the mainstay for staging and post-therapy surveillance of cancer as malignant neoplasms generally demonstrate higher FDG uptake that...
2.
Shen Y, Gosnell J, Nawgiri R, Muthukumarana V
J Am Soc Cytopathol . 2024 Apr; 13(4):303-308. PMID: 38637263
Introduction: Serous fluids offer crucial diagnostic insights, but inconsistent analysis hampers reporting quality, especially in indeterminate (ID) categories like atypia of undetermined significance (AUS) and suspicious for malignancy (SFM). The...
3.
Hussain M, Rawas F, Ali Y, Edhayan G, Lyapichev K, Nawgiri R
Diagn Cytopathol . 2023 Jun; 51(9):E259-E262. PMID: 37329326
Fine needle aspirations are infrequently performed on the spleen due to concerns for hemorrhagic complications. As a result, splenic lesions can be challenging to diagnose given the limited amount of...
4.
Homma K, Bazhanov N, Hashimoto K, Shimizu M, Heathman T, Hao Q, et al.
Front Immunol . 2023 May; 14:1136964. PMID: 37180159
Introduction: The pathogenesis of sepsis is an imbalance between pro-inflammatory and anti-inflammatory responses. At the onset of sepsis, the lungs are severely affected, and the injury progresses to acute respiratory...
5.
Homma K, Liu K, Niimi Y, Fukuda S, Hirasawa Y, Baljinnyam T, et al.
Shock . 2023 Mar; 59(5):810-819. PMID: 36870071
In preclinical studies, the protective effects of female sex hormones and the immunosuppressive effects of male sex hormones were demonstrated. However, gender-related differences in multiorgan failure and mortality in clinical...
6.
Bigham L, Rawas F, Vinnakota R, Venkatesan R, Nawgiri R, Mallick J, et al.
EJHaem . 2022 Jul; 3(2):551-552. PMID: 35846059
No abstract available.
7.
Bhakta P, Youssef A, Bigham L, Mallick J, Bhargava P, Rawas F, et al.
Head Neck Pathol . 2022 Jul; 16(4):1091-1102. PMID: 35802244
Background: Primary bone lymphoma is a rare type of lymphoid neoplasm with favorable prognosis, where Primary Non Hodgkin Lymphoma of bone (PB-NHL) is most common with the subtype. Amongst PB-NHL,...
8.
Nelson B, Hong A, Okereke I, Markowitz A, Willis M, Muthukumarana P, et al.
Diagn Cytopathol . 2021 Jul; 49(10):1150-1154. PMID: 34331523
Nivolumab is commonly used as monotherapy or in combination therapy for management of locally advanced or metastatic melanoma; however, it is also associated with immunotherapy-related adverse events concerning for disease...
9.
Iqbal F, Shokrzadeh C, Nawgiri R, Okereke I
JTCVS Tech . 2021 Jul; 2:168-170. PMID: 34317793
No abstract available.
10.
Rivera Rolon M, Schnadig V, Faiz S, Nawgiri R, Clement C
Diagn Cytopathol . 2020 May; 48(11):1067-1074. PMID: 32452653
Background: The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) is based on risk stratification. We presented our experience with fine-needle aspiration cytology (FNAC) for the diagnosis of salivary glands...